Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ariel Barkan

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Pituitary|November 19, 2013
Tamoxifen as a therapeutic agent in acromegalyIrida Balili, Ariel Barkan
Pituitary|August 31, 2012
Estrogen treatment for acromegalyIlan Shimon, Ariel Barkan
Pituitary|August 11, 2010
Quantification of day-to-day variability in growth hormone levels in acromegalyAndrew Kraftson, Ariel Barkan
Endocrinology and Metabolism Clinics of North America|March 6, 2007
Factors regulating growth hormone secretion in humansNaila Goldenberg, Ariel Barkan
Nature Clinical Practice. Endocrinology & Metabolism|April 24, 2008
Long-term effects of pegvisomant in patients with acromegalyIsrael Hodish, Ariel Barkan
Clinical Diabetes and Endocrinology|July 14, 2017
Clinical case seminar: unraveling the mystery of abnormal thyroid function testsAriel Barkan, Ronald J Koenig
The Journal of Clinical Endocrinology and Metabolism|November 22, 2007
Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of different sampling modelsKatica Bajuk Studen, Ariel Barkan
Nature Reviews. Endocrinology|June 27, 2012
The changing face of acromegaly--advances in diagnosis and treatmentAntônio Ribeiro-Oliveira, Ariel Barkan
Pituitary|October 24, 2018
Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapyAdnan Ajmal, Erin McKean, Stephen Sullivan, et al.
Pituitary|May 7, 2013
Pituitary carcinoma with endolymphatic sac metastasisIrida Balili, Steven Sullivan, Paul Mckeever, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Pituitary|November 19, 2013
Tamoxifen as a therapeutic agent in acromegalyIrida Balili, Ariel Barkan
Pituitary|August 31, 2012
Estrogen treatment for acromegalyIlan Shimon, Ariel Barkan
Pituitary|August 11, 2010
Quantification of day-to-day variability in growth hormone levels in acromegalyAndrew Kraftson, Ariel Barkan
Endocrinology and Metabolism Clinics of North America|March 6, 2007
Factors regulating growth hormone secretion in humansNaila Goldenberg, Ariel Barkan
Nature Clinical Practice. Endocrinology & Metabolism|April 24, 2008
Long-term effects of pegvisomant in patients with acromegalyIsrael Hodish, Ariel Barkan
Clinical Diabetes and Endocrinology|July 14, 2017
Clinical case seminar: unraveling the mystery of abnormal thyroid function testsAriel Barkan, Ronald J Koenig
The Journal of Clinical Endocrinology and Metabolism|November 22, 2007
Assessment of the magnitude of growth hormone hypersecretion in active acromegaly: reliability of different sampling modelsKatica Bajuk Studen, Ariel Barkan
Nature Reviews. Endocrinology|June 27, 2012
The changing face of acromegaly--advances in diagnosis and treatmentAntônio Ribeiro-Oliveira, Ariel Barkan
Pituitary|October 24, 2018
Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapyAdnan Ajmal, Erin McKean, Stephen Sullivan, et al.
Pituitary|May 7, 2013
Pituitary carcinoma with endolymphatic sac metastasisIrida Balili, Steven Sullivan, Paul Mckeever, et al.
Pageof 4